INOVIO, a biotech company specializing in DNA medicines for HPV-related diseases and cancer, announced its participation in two major June 2026 events: the Jefferies Global Healthcare Conference in New York on June 4 and the World Orphan Drug Congress in Boston on June 11. The company will present a poster on next-generation DNA medicine for rare disease protein replacement and hold investor meetings. These events highlight INOVIO’s ongoing efforts to advance DNA-based therapies and engage with the investment community.